Page 89 

Chapter 5 Calculating parenteral doses

small volume

Learning outcomes

Be able to interpret a range of prescriptions of small-volume injections
Be able to interpret a range of labels used for small-volume injections
Understand the significance of displacement volume
Through practice gain confidence in calculating the amount to give the patient based on: (a) ‘prescriptions’ and ‘medicine labels’, (b) information in abbreviated tabular form

Introduction

Following discussion of some of the essential elements of calculating doses of parenteral drugs, examples of calculations are presented at the different levels of complexity described in Chapter 3. They are presented in the same three ways as in Chapter 4, namely:

Fully worked-up calculation demonstrations
Examples to practise in a similar format
Examples to practise in abridged form

All answers are given on p. 195.

Interpretation of the prescription and the label of a parenteral preparation follows the same principles as a non-parenteral preparation.

Equipment for measuring the dose

Medicines for injection are presented in either a glass or plastic ampoule (Fig. 5.1), a rubber-capped vial (Fig. 5.2) or a prefilled syringe or a cartridge (Fig. 5.3). The contents are either in the form of a liquid or presented as a powder requiring reconstitution. To aspirate the contents, a syringe and needle of suitable size are selected. Care must be taken to draw up the correct amount into the syringe. It is therefore essential to appreciate the significance of the calibrations on different syringes (Fig. 5.4). The syringe should be held at eye level and air should be expelled. The reading should be taken at the top of the black bung attached to the plunger of the syringe. When drawing up and giving insulin, a syringe (with integral needle), specifically for insulin calibrated in units, will normally be used (Fig. 5.5).

image

Figure 5.1 Ampoule (glass).

image

Figure 5.2 Rubber-capped vial.

image

Figure 5.3 Cartridge.

image

Figure 5.4 Syringes showing different calibrations.

image

Figure 5.5 Insulin syringe showing calibrations.

  Page 90 
  Page 91 

Safety

When administering cytotoxic drugs (and other potentially dangerous compounds), it is essential to follow local safety protocols and procedures.

Overage

When preparing to draw up an injection, it should be noted that ampoules containing a solution for injection always contain more than the nominal volume. For example, a 1 mL ampoule will normally contain a total volume of 1.1 mL. An overage of 0.1 mL is present so as to allow removal of a full 1 mL dose, otherwise it would not be possible to remove 1 mL due to the ‘losses’ of injection solution on the internal surfaces of the ampoule. Larger-volume ampoules contain overages in proportion to the nominal volume.

It follows therefore that it is very important to measure all doses and not simply to draw up the contents of the ampoule. The presence of overages in ampoules is one reason why it is not acceptable to measure doses in terms of, for example, half an ampoule. A 1 mL ampoule with a strength of 10 mg per 1 mL will contain 11 mg in 1.1 mL. Giving a dose of half the contents of the ampoule could introduce a drug error in this case 5.5 mg rather than the required 5 mg. There is no substitute for measuring the dose accurately. It should be noted that labels of Controlled Drugs show the presence of an overage for legal reasons.

Displacement volumes

A number of drugs are unstable in solution (both parenteral and oral) and are therefore supplied in dry powder form. Prior to administration, the powder must be reconstituted using a diluent (or solvent). Water for injections is commonly used but sodium chloride 0.9% solution may be the recommended diluent; on occasion, a specially formulated diluent may be provided. Enough liquid is needed to dissolve (or suspend) the contents to produce a concentration that prevents irritation of body tissues but at the same time is of minimum volume so as to make the injection less painful.

  Page 92 

The addition of 5 mL of a diluent to a vial containing 500 mg of a drug in powder form will produce a volume of more than 5 mL due to the presence of the powder (Fig. 5.6). It can be seen in Fig. 5.6 that the powder has added 0.2 mL to the volume of diluent added. The displacement volume (DV) is the volume of liquid displaced by the powder, in this case, 0.2 mL. If the dose to be administered is less than 500 mg, it will be important to take account of the displacement value (Cable 2008).

image

Figure 5.6 Displacement of liquid when reconstituting an injection.

A dose of 250 mg of a drug is to be administered from the 500 mg vial. The contents of the vial of 500 mg displace 0.2 mL of diluent. It is therefore necessary to add to the vial 5 mL minus 0.2 mL, which equals 4.8 mL, to produce a total volume of solution of 5 mL. The resulting solution contains 500 mg in 5 mL.

To obtain the required dose, the usual formula can then be applied:

image

If allowance is not made for the DV, measuring and administering a dose of 2.5 mL would result in a drug error. Thus, if 5 mL of a diluent was added (not taking account of the DV), a total volume of 5.2 mL would be produced. The dose of 250 mg would be contained in:


image


  Page 93 

Displacement volumes will normally be found in the product literature. If for some reason the DV is not known, a suitable volume of diluent is added to the vial in the usual way and the powder fully dissolved. The total contents of the vial are measured by drawing into a syringe. The required dose can then be calculated.

It is important to note that all powders (including those for oral administration) intended to be reconstituted before use will also displace a certain volume of diluent. Powder for colistin syrup displaces 22 mL of water when made up to the required volume of 80 mL, i.e. 58 mL (80–22 mL) of water must be added to produce a final volume of 80 mL.

Exercise 5.1

Work out the following taking account of the displacement volume.

A patient is to be administered 500 mg of amoxicillin by intramuscular injection every 8 hours. The displacement volume of amoxicillin is 0.4 mL for a 500 mg vial. If 2.5 mL water for injections is added and a solution made, what is the volume to be administered to give a dose of 500 mg?

How to calculate the quantity to give of small-volume injections

Level 0: Demonstration

Demonstration 5.1

Prescription

image

The medicine

Ranitidine (Zantac) is available in a number of formulations including an injection containing 25 mg/mL (2 mL ampoule)

Commentary

Ranitidine is an H2 receptor antagonist used to treat benign gastric and duodenal ulceration
No calculation is involved here since the prescribed dose corresponds to the strength on the label

The patient will be given:

2 mL IM injection

  Page 94 

Level I: Demonstration

Demonstration 5.2

Prescription

image

Medicine label

image

Commentary

Diclofenac is an NSAID used to reduce pain and inflammation
This is another straightforward example
If in doubt, use the formula

Workings

The prescribed dose (50 mg) is less than the amount contained in 3 mL

Applying the formula,

image

The patient will be given:

2 mL IM injection

  Page 95 

Level I: Exercises

Exercise 5.2

Prescription

image

Medicine label

image

Commentary

Phentolamine is a short-acting alpha blocker used in the diagnosis and treatment of acute hypertensive episodes of phaeochromocytoma

What should the patient be given?

  Page 96 

Exercise 5.3

Prescription

image

Medicine label

image

Commentary

Verapamil is used to treat supraventricular arrhythmias

What should the patient be given?

  Page 97 

Exercise 5.4

Prescription

image

Medicine label

image

Commentary

Terbutaline is a short-acting beta2 agonist used in the treatment of asthma and other conditions associated with reversible airways obstruction
0.5 mg = 500 micrograms

What should the patient be given?

  Page 98 

Level I: Further exercises

In the following examples, calculate what you should give the patient.

‘Prescription’

5.5 Zuclopenthixol decanoate 600 mg deep IM injection
5.6 Diazepam 10 mg IM injection
5.7 Furosemide 40 mg IM injection
5.8 Hydrocortisone 300 mg IM injection
5.9 Fluphenazine 12.5 mg deep IM injection
5.10 Hyoscine hydrobromide 200 micrograms SC injection
5.11 Procyclidine 10 mg IM injection
5.12 Octreotide 150 micrograms SC injection

‘Medicine label’

200 mg/mL injection
5 mg/mL injection
10 mg/mL injection
100 mg/mL injection
25 mg/mL injection
400 micrograms/mL injection
5 mg/mL injection
100 micrograms/mL injection
  Page 99 

Level II: Demonstration

Demonstration 5.3

Prescription

image

Medicine label

image

Commentary

Benzatropine is an antimuscarinic which reduces extrapyramidal symptoms induced by antipsychotic drugs
The prescription and the medicine label are in different units. A conversion to the same units is needed
The prescribed dose is less than the amount contained in 1 mL of injection

Workings

The dose available is 1 mg/mL, which is the same as 1000 micrograms/mL.

Applying the formula,

image

The patient will be given:


image


  Page 100 

Level II: Exercises

Exercise 5.13

Prescription

image

Medicine label

image

Commentary

Glycopyrronium is an antimuscarinic drug with several indications

What should the patient be given?

  Page 101 

Exercise 5.14

Prescription

image

Medicine label

image

Commentary

Atropine is an antimuscarinic drug

What should the patient be given?

  Page 102 

Exercise 5.15

Prescription

image

Medicine label

image

Commentary

Diazepam is a benzodiazepine anxiolytic

What should the patient be given?

Exercise 5.16

Prescription

image

The medicine

Alfacalcidol (One-Alpha) is available as an injection containing 2 micrograms in 1 mL

Commentary

Alfacalcidol is used to treat hypocalcaemia in dialysis patients with severe renal impairment

What should the patient be given?

  Page 103 

Exercise 5.17

Prescription

image

Medicine label

image

Commentary

Cefotaxime is a broad-spectrum antibiotic
Note, 2 mL is the final volume taking into account the displacement volume

What should the patient be given?

Exercise 5.18

Prescription

image

The medicine

Edrophonium is available as a 10 mg/mL injection

Commentary

Edrophonium is an anticholinesterase used in anaesthesia and in the diagnosis of myasthenia gravis

What should the patient be given?

  Page 104 

Exercise 5.19

Prescription

image

Medicine label

image

Commentary

Phenylephrine is a vasoconstrictor sympathomimetic used to treat acute hypotension

What should the patient be given?

  Page 105 

Exercise 5.20

Prescription

image

Medicine label

image

Commentary

Heparin is a parenteral anticoagulant
Available in a number of different strengths (all in units)
Take particular care in selecting the most appropriate preparation

What should the patient be given?

Level II: Further exercises

In the following examples, calculate what you should give the patient.

‘Prescription’

5.21 Methadone 7.5 mg SC
5.22 Sodium aurothiomalate 10 mg IM
5.23 Triamcinolone 2.5 mg intra-articular injection
5.24 Ondansetron 8 mg IM
5.25 Buprenorphine 450 micrograms IV
5.26 Adrenaline 300 micrograms IM
5.27 Salbutamol 250 micrograms slow IV

‘Medicine label’

10 mg/mL injection
20 mg/mL injection
10 mg/mL injection
2 mg/mL injection
300 micrograms/mL injection
1 in 1000 (1 mg in 1 mL)
500 micrograms/mL
  Page 106 

Level III: Demonstration

Demonstration 5.4

Prescription

image

Medicine label

image

Commentary

Ganciclovir is used to treat life-threatening or sight-threatening cytomegalovirus infections in immunocompromised patients
The patient weighs 60 kg
The IV powder has to be reconstituted. Assume that 10 mL is the total volume after water for injections has been added
Ganciclovir is toxic and personnel handling this product require suitable protection

Workings

Multiply patient's weight by dose prescribed to get dose to be given,


image


To establish the volume to give, apply the formula,

image

The patient will be given:


image


  Page 107 

Demonstration 5.5

Prescription

image

Medicine label

image

Commentary

Lorazepam is used as an anxiolytic, in insomnia, as a premedication and in status epilepticus
The patient weighs 70 kg
For IM injection, it should be diluted with an equal volume of water for injections or physiological saline

Workings

For a 70 kg patient, the dose required is:


image


The strength available is 4 mg/mL, which is the same as 4000 micrograms/mL

The prescribed dose is less than the amount contained in 1 mL

Applying the formula,

image

The patient will be given:


image


  Page 108 

Level III: Further exercises

5.28 2.4 mg hyoscine hydrobromide is prescribed by IM injection daily in 4 divided doses. The injection available is 600 micrograms/mL. What volume would you give for each dose?
5.29 A 65 kg adult is prescribed 6 mg/kg of teicoplanin once daily by IV injection. 200 mg teicoplanin powder, when reconstituted, is available in 3 mL. What volume would you administer?
5.30 A 70 kg adult with tetanus is prescribed diazepam 200 micrograms/kg by IV injection. Diazepam 5 mg/mL injection is available. What volume is administered?
5.31 A 60 kg patient requires to be treated for a deep-vein thrombosis by SC injection of enoxaparin sodium at a dose of 1.5 mg/kg (150 units/ kg) every 24 hours. A series of syringes is available containing increasing doses from 0.2 mL (20 mg, 2000 units) to 1 mL (150 mg, 15 000 units). You select the syringe containing 1 mL (100 mg, 10 000 units). What volume is administered?
5.32 A patient has a pulmonary embolism and is prescribed tinzaparin 175 units/kg once daily. The patient weighs 69 kg. What volume of injection is administered from a 0.8 mL syringe containing 14 000 units?
5.33 A 67 kg patient is prescribed amikacin 22.5 mg/kg daily in 3 divided doses. What volume of 250 mg/mL injection is administered per dose?

Syringe driver

Syringe drivers and pumps are small, lightweight, battery-operated, portable devices designed to deliver a steady rate of drugs. They are mostly used to administer medication by the subcutaneous (SC) or the intravenous (IV) routes for symptom management and palliative care (Dickman et al 2005).

There may be a calculation required when filling the syringe. Otherwise, being simply another type of delivery system, the syringe driver presents no more difficulty than calculations by any other route. As much care is required in reading the prescription and the details on the label as when preparing to administer any other medicine. The amount of diluent is dependent on the number and volume of the drugs to be delivered.

Once the syringe is filled with the appropriate amount of drug(s) and diluent, it is attached to an infusion set designed for the purpose. When using the SC route, the infusion set should have a previously attached plastic cannula or ‘butterfly’ needle; for the IV route, the infusion set, once primed, is attached to an already-sited IV cannula. When the syringe is filled, the tubing has been primed and the needle/cannula is in place/attached, the rate the plunger is to advance must be set in accordance with the prescription.

Syringe drivers can be set at:


image


  Page 109 

These settings express the distance travelled by the plunger within a span of time, and not the volume of drug. If both types of syringe drivers are available, great care must be taken when setting up, since a 24-fold error can occur.

It is good practice once the infusion has commenced to check within the first half hour that the plunger is proceeding as intended and that the patient is comfortable. A check thereafter at least every 4 hours should suffice unless local policy dictates otherwise.

Syringe pump

A syringe pump is a computerised device in which the rate of flow is controlled by the speed of the piston attached to the syringe plunger. Small volumes of highly concentrated drugs may be administered intravenously by this method, usually via a 60 mL syringe. The rate is set in millilitres per hour. A syringe pump may be used for the administration of drugs by the IV route or, in palliative care, by the SC or epidural route. The amount to be given and the amount that has been given are displayed on an LCD.

In the interests of patient safety, health authorities are being encouraged to standardise the models in use. Some of the existing devices do not meet the standard set by the MHRA (2009). Choice, maintenance and availability of syringe drivers and pumps need to be carefully considered and budgeted for. The aim is to have a library of devices that can be consistently maintained by medical physics staff and loaned. No ward would ‘own’ devices but would borrow them as required.

References

Cable C. Why a knowledge of displacement values is important for pharmacists. The Pharmaceutical Journal. 2008;2281:244-245.

Dickman A., Schneider J., Varga J. The syringe driver: continuous subcutaneous infusions in palliative care. Oxford: Oxford Publications, 2005.

MHRA. Devices in practice: a guide for professionals in health and social care. London: Medicines and Healthcare products Regulatory Agency, 2009.